Exact Mass: 351.1504

Exact Mass Matches: 351.1504

Found 200 metabolites which its exact mass value is equals to given mass value 351.1504, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

trans-zeatin riboside

(2R,3R,4S,5R)-2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


Trans-zeatin riboside, also known as (E)-N-(4-hydroxy-3-methyl-2-butenyl)adenosine or 9-beta-D-ribofuranosyl-trans-zeatin, is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Trans-zeatin riboside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Trans-zeatin riboside can be found in a number of food items such as winter squash, plains prickly pear, dill, and common buckwheat, which makes trans-zeatin riboside a potential biomarker for the consumption of these food products. D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins Acquisition and generation of the data is financially supported in part by CREST/JST. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

O-beta-D-Xyloxylzeatin

O-beta-D-Xylosylzeatin; O-beta-D-Xyloxylzeatin

C15H21N5O5 (351.1543)


   

Ochotensine

(+)-Ochotensine

C21H21NO4 (351.1471)


   

Aniflorine

Pyrrolo[2,1-b]quinazolin-9(1H)-one, 3-[2-(dimethylamino)phenyl]-2,3-dihydro-3-hydroxy-5-methoxy-

C20H21N3O3 (351.1583)


   

Zindoxifene

Zindoxifene

C21H21NO4 (351.1471)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent

   

cis-zeatin riboside

cis-zeatin riboside

C15H21N5O5 (351.1543)


   

ribosylzeatin

(3R,4S,5R)-2-(((E)-4-((7H-purin-6-yl)amino)-2-methylbut-2-en-1-yl)oxy)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;trans-Zeatinriboside

C15H21N5O5 (351.1543)


9-ribosyl-trans-zeatin is a 9-ribosylzeatin having trans-zeatin as the nucleobase. It has a role as a plant metabolite and a cytokinin. It is a nucleoside analogue and a 9-ribosylzeatin. It is functionally related to an adenosine. Zeatin riboside is a natural product found in Rhodococcus fascians, Pseudomonas syringae, and other organisms with data available. D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins A 9-ribosylzeatin having trans-zeatin as the nucleobase. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

9-(beta-D-Ribofuranosyl)zeatin

2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


9-(beta-D-Ribofuranosyl)-(Z)-Zeatin is found in alfalfa. Zeatin is a plant hormone derived from the purine adenine. It is a member of the plant growth hormone family known as cytokinins. Zeatin was first discovered in immature corn kernels from the genus Zea. Zeatin and derivatives were discovered to be the primary active ingredient in coconut milk, which has long been known to actively induce plant growth. As in the case of kinetin, zeatin has also been reported to have several in vitro anti-aging effects on human skin fibroblasts.(Wikipedia). Isolated from many plants. (E)-Ribosylzeatin is found in many foods, some of which are cauliflower, chicory, chayote, and wild carrot. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

Phenylalanyltryptophan

(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C20H21N3O3 (351.1583)


Phenylalanyltryptophan is a dipeptide composed of phenylalanine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. H-Phe-Trp-OH (Phenylalanyltryptophan) is an endogenous metabolite[1]. H-Phe-Trp-OH (Phenylalanyltryptophan) is an endogenous metabolite[1].

   

Tryptophyl-Phenylalanine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-phenylpropanoate

C20H21N3O3 (351.1583)


Tryptophyl-Phenylalanine is a dipeptide composed of tryptophan and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

(2R,3S,5R)-2-[6-[[(1S,2S)-2-Hydroxycyclopentyl]amino]-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

(2R,3S,5R)-2-[6-[[(1S,2S)-2-Hydroxycyclopentyl]amino]-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


   

benfluorex

2-({1-[3-(trifluoromethyl)phenyl]propan-2-yl}amino)ethyl benzoic acid

C19H20F3NO2 (351.1446)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D009676 - Noxae > D000963 - Antimetabolites

   

Estradiol sulfamate

(17-Hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl) sulfamate

C18H25NO4S (351.1504)


   

cis-zeatin riboside

2-(6-{[(2Z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


Cis-zeatin riboside is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Cis-zeatin riboside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Cis-zeatin riboside can be found in a number of food items such as american pokeweed, sesbania flower, moth bean, and common chokecherry, which makes cis-zeatin riboside a potential biomarker for the consumption of these food products.

   

9-Ribosyl-cis-zeatin

6-(4-Hydroxy-3-methyl-cis-2-butenylamino)-9-beta-D-ribofuranosylpurine

C15H21N5O5 (351.1543)


   
   

Dehydroglaucine

Dehydroglaucine

C21H21NO4 (351.1471)


   

O-Demethyl-buchenavianine

O-Demethyl-buchenavianine

C21H21NO4 (351.1471)


   

benfluorex

benfluorex

C19H20F3NO2 (351.1446)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D009676 - Noxae > D000963 - Antimetabolites

   

Maybridge2_000779

Maybridge2_000779

C22H19F2NO (351.1435)


   

N-(2-Hydroxycyclopentyl)adenosine

N-(2-Hydroxycyclopentyl)adenosine

C15H21N5O5 (351.1543)


   

(-)-phyllosteminine|Phyllosteminine

(-)-phyllosteminine|Phyllosteminine

C21H21NO4 (351.1471)


   

9-(beta-D-Ribofuranosyl)zeatin

9-(beta-D-Ribofuranosyl)zeatin

C15H21N5O5 (351.1543)


   
   

methyldambullin|N-Me-Dambullin

methyldambullin|N-Me-Dambullin

C18H25NO4S (351.1504)


   

Validoxylamine G

Validoxylamine G

C14H25NO9 (351.1529)


   

SCHEMBL5160426

SCHEMBL5160426

C14H25NO9 (351.1529)


   

(+)-(6aR,7R)-N-butyrylnorushinsunine

(+)-(6aR,7R)-N-butyrylnorushinsunine

C21H21NO4 (351.1471)


   
   

castanospermine-8-O-beta-D-glucopyranoside

castanospermine-8-O-beta-D-glucopyranoside

C14H25NO9 (351.1529)


   

CHEMBL2029616

CHEMBL2029616

C21H21NO4 (351.1471)


   

O-Demethylbuchenavianine

O-Demethylbuchenavianine

C21H21NO4 (351.1471)


A piperidine alkaloid that consists of 5,7-dihydroxyflavone attached to a 1-methylpiperindin-2-yl moiety at position 8. It is a flavonoid alkaloid isolated from Buchenavia capitata, and has been shown to exhibit anti-HIV activity.

   

Isoochotensine

Isoochotensine

C21H21NO4 (351.1471)


   
   

1-epi-australine-2-O-beta-D-glucopyranoside

1-epi-australine-2-O-beta-D-glucopyranoside

C14H25NO9 (351.1529)


   
   
   
   
   

RCS-4 N-(5-carboxypentyl) metabolite

RCS-4 N-(5-carboxypentyl) metabolite

C21H21NO4 (351.1471)


   
   
   
   
   
   
   
   

13-Methylcolumbamine

13-Methylcolumbamine

C21H21NO4 (351.1471)


   

9-Ribosyl-trans-zeatin

9-Ribosyl-trans-zeatin

C15H21N5O5 (351.1543)


CONFIDENCE standard compound; ML_ID 23

   

Cis-Zeatin-riboside-[d5]

Cis-Zeatin-riboside-[d5]

C15H21N5O5 (351.1543)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Cis-Zeatin-riboside

Cis-Zeatin-riboside

C15H21N5O5 (351.1543)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

trans-Zeatin-riboside

trans-Zeatin-riboside

C15H21N5O5 (351.1543)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Trans-Zeatin-riboside-[d5]

Trans-Zeatin-riboside-[d5]

C15H21N5O5 (351.1543)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Trans-zeatin riboside

N-(4-hydroxy-3-methyl-2-butenyl)adenosine

C15H21N5O5 (351.1543)


trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

9-ribosylzeatin

trans-Zeatin-riboside

C15H21N5O5 (351.1543)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.545 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.538 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.540

   

N-2-Hydroxycyclopentyladenosine

N-2-Hydroxycyclopentyladenosine

C15H21N5O5 (351.1543)


   
   
   
   
   
   
   
   
   
   
   

Phe-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C20H21N3O3 (351.1583)


A dipeptide formed from L-phenylalanine and L-tryptophan residues.

   

TRP-Phe

2-(2-amino-3-phenylpropanamido)-3-(1H-indol-3-yl)propanoic acid

C20H21N3O3 (351.1583)


A dipeptide formed from L-tryptophan and L-phenylalanine residues.

   

ribosylzeatin

2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

alizapride hydrochloride

alizapride hydrochloride

C16H22ClN5O2 (351.1462)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Alizapride is a potent antiemetic, acting as a dopamine receptor antagonist. Alizapride also used in human digestive disorders[1][3].

   

Fmoc-D-Pipecolic Acid

Fmoc-D-Pipecolic Acid

C21H21NO4 (351.1471)


   

moquizone

moquizone

C20H21N3O3 (351.1583)


C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents

   

(Rac)-Rotigotine hydrochloride

(Rac)-Rotigotine hydrochloride

C19H26ClNOS (351.1424)


(Rac)-Rotigotine hydrochloride is a racemate of Rotigotine. Rotigotine is a full agonist of?dopamine receptor, a partial agonist of the?5-HT1A receptor, and an antagonist of the?α2B-adrenergic receptor, with?Kis of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors, and dopamine D1 receptor.

   

(R)-N-Fmoc-2-(3-butenyl)glycine

(R)-N-Fmoc-2-(3-butenyl)glycine

C21H21NO4 (351.1471)


   

N-Fmoc-L-pipecolic acid

N-Fmoc-L-pipecolic acid

C21H21NO4 (351.1471)


   

5,6,7,8-Tetrahydro-6-[propyl[2-(3-thienyl)ethyl]amino]-1-naphthalenol hydrochloride

5,6,7,8-Tetrahydro-6-[propyl[2-(3-thienyl)ethyl]amino]-1-naphthalenol hydrochloride

C19H26ClNOS (351.1424)


   
   
   

(-)-(1R,3S)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

(-)-(1R,3S)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

C21H21NO4 (351.1471)


   

(R)-N-Fmoc-2-(2-propylenyl)alanine

(R)-N-Fmoc-2-(2-propylenyl)alanine

C21H21NO4 (351.1471)


   

4-(2-carboxy-6-nitro-phenyl)-piperazine-1-carboxylic acid tertier-butyl ester

4-(2-carboxy-6-nitro-phenyl)-piperazine-1-carboxylic acid tertier-butyl ester

C16H21N3O6 (351.143)


   

N-[(2-Methyl-1H-benzimidazol-1-yl)acetyl]-L-phenylalanine

N-[(2-Methyl-1H-benzimidazol-1-yl)acetyl]-L-phenylalanine

C20H21N3O3 (351.1583)


   

3-(4-METHOXYPHENYL)-5-ISOXAZOLYL]METHANAMINE

3-(4-METHOXYPHENYL)-5-ISOXAZOLYL]METHANAMINE

C21H21NO4 (351.1471)


   

2-CHLORO-5-METHYL-1,4-BENZOQUINONE

2-CHLORO-5-METHYL-1,4-BENZOQUINONE

C21H21NO4 (351.1471)


   

(+)-(1S,3R)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

(+)-(1S,3R)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

C21H21NO4 (351.1471)


   

Fmoc-(S)-3-Amino-5-hexenoic acid

Fmoc-(S)-3-Amino-5-hexenoic acid

C21H21NO4 (351.1471)


   

fmoc-l-cyclopropylalanine

fmoc-l-cyclopropylalanine

C21H21NO4 (351.1471)


   

4-(BOC-PIPERAZIN-1-YL)-3-NITROBENZOIC A&

4-(BOC-PIPERAZIN-1-YL)-3-NITROBENZOIC A&

C16H21N3O6 (351.143)


   

2-[[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]METHYL]PHTHALIMIDE

2-[[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]METHYL]PHTHALIMIDE

C21H21NO4 (351.1471)


   
   

Fmoc- DL -Nip-OH

Fmoc- DL -Nip-OH

C21H21NO4 (351.1471)


   

1-Boc-4-Benzyloxy-3-formylindole

1-Boc-4-Benzyloxy-3-formylindole

C21H21NO4 (351.1471)


   

tert-Butyl 6-(benzyloxy)-3-formyl-1H-indole-1-carboxylate

tert-Butyl 6-(benzyloxy)-3-formyl-1H-indole-1-carboxylate

C21H21NO4 (351.1471)


   

rotigotine hydrochloride

rotigotine hydrochloride

C19H26ClNOS (351.1424)


Rotigotine Hydrochloride (N-0923 Hydrochloride) is a full agonist of dopamine receptor, a partial agonist of the 5-HT1A receptor, and an antagonist of the α2B-adrenergic receptor, with Ki of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors, and dopamine D1 receptor.

   

Solvent Orange 14

Solvent Orange 14

C22H17N5 (351.1484)


   

(1R,2R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)CYCLOPENTANECARBOXYLIC ACID

(1R,2R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)CYCLOPENTANECARBOXYLIC ACID

C21H21NO4 (351.1471)


   

Fmoc-(R)-3-Amino-5-hexenoic acid

Fmoc-(R)-3-Amino-5-hexenoic acid

C21H21NO4 (351.1471)


   

1-N-BOC-4-(3-CARBOXY-4-NITROPHENYL)PIPERAZINE

1-N-BOC-4-(3-CARBOXY-4-NITROPHENYL)PIPERAZINE

C16H21N3O6 (351.143)


   

H-Glu-Gly-Phe-OH

H-Glu-Gly-Phe-OH

C16H21N3O6 (351.143)


   

Fmoc-D-Nip-OH

Fmoc-D-Nip-OH

C21H21NO4 (351.1471)


   

4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid

4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid

C21H21NO4 (351.1471)


   

FMOC-D-CYCLOPROPYLALANINE

FMOC-D-CYCLOPROPYLALANINE

C21H21NO4 (351.1471)


   

Fmoc-L-beta-Homoproline

Fmoc-L-beta-Homoproline

C21H21NO4 (351.1471)


   

Fmoc-4,5-Dehydro-L-Leucine

Fmoc-4,5-Dehydro-L-Leucine

C21H21NO4 (351.1471)


   

1-(3-AZIDO-2,3-DIDEOXY-5-O-PIVALOYL-BETA-D-ERYTHRO-PENTOFURANOSYL)-THYMINE

1-(3-AZIDO-2,3-DIDEOXY-5-O-PIVALOYL-BETA-D-ERYTHRO-PENTOFURANOSYL)-THYMINE

C15H21N5O5 (351.1543)


   

N-octyl-3-metylpyridinium hexafluorophosphate

N-octyl-3-metylpyridinium hexafluorophosphate

C14H24F6NP (351.155)


   

1-BOC-5-BENZYLOXY-3-FORMYLINDOLE

1-BOC-5-BENZYLOXY-3-FORMYLINDOLE

C21H21NO4 (351.1471)


   

1-BOC-7-BENZYLOXY-3-FORMYLINDOLE

1-BOC-7-BENZYLOXY-3-FORMYLINDOLE

C21H21NO4 (351.1471)


   

N-Fmoc-1-amino-1-cyclopentanecarboxylic acid

N-Fmoc-1-amino-1-cyclopentanecarboxylic acid

C21H21NO4 (351.1471)


   

Fmoc-D-beta-homoproline

Fmoc-D-beta-homoproline

C21H21NO4 (351.1471)


   

Fmoc-(S)-2-(2-propenyl)Ala-OH

Fmoc-(S)-2-(2-propenyl)Ala-OH

C21H21NO4 (351.1471)


   

Estradiol 3-sulfamate

Estradiol 3-sulfamate

C18H25NO4S (351.1504)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

N-((1S,trans)-2-Hydroxycyclopentyl)adenosine

N-((1S,trans)-2-Hydroxycyclopentyl)adenosine

C15H21N5O5 (351.1543)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites GR79236 is a highly potent, selective and orally active adenosine A1 receptor agonist with a Kis of 3.1 nM and 1300 nM for A1 and A2 receptors, respectively. GR79236 has anti-nociceptive and anti-inflammatory actions[1][2]. GR79236 is a highly potent, selective and orally active adenosine A1 receptor agonist with a Kis of 3.1 nM and 1300 nM for A1 and A2 receptors, respectively. GR79236 has anti-nociceptive and anti-inflammatory actions[1][2].

   

3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide

3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide

C18H20F3N3O (351.1558)


   

Carbol-Fuchsin

Carbol-Fuchsin

C21H22ClN3 (351.1502)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   

8-(Mesitylthio)-9-(pent-4-yn-1-yl)-9H-purin-6-amine

8-(Mesitylthio)-9-(pent-4-yn-1-yl)-9H-purin-6-amine

C19H21N5S (351.1518)


   

(1S,2S,3R,4S,5R,6S)-4-(hydroxymethyl)-6-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,5-tetrol

(1S,2S,3R,4S,5R,6S)-4-(hydroxymethyl)-6-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,5-tetrol

C14H25NO9 (351.1529)


   
   
   

4-(2-(2-Chlorophenyl)ethyl)amino-8-methoxy-3,10-dimethyl-2,9-dioxatricyclo(4,3,1,0(3,7))decane

4-(2-(2-Chlorophenyl)ethyl)amino-8-methoxy-3,10-dimethyl-2,9-dioxatricyclo(4,3,1,0(3,7))decane

C19H26ClNO3 (351.1601)


   

L-Alanyl-L-phenylalanyl-L-aspartic acid

L-Alanyl-L-phenylalanyl-L-aspartic acid

C16H21N3O6 (351.143)


   

(2R,3S,5R)-2-[6-[[(1S,2S)-2-Hydroxycyclopentyl]amino]-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

(2R,3S,5R)-2-[6-[[(1S,2S)-2-Hydroxycyclopentyl]amino]-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites

   

N-(2-aminophenyl)-1-butyl-4-hydroxy-2-oxo-3-quinolinecarboxamide

N-(2-aminophenyl)-1-butyl-4-hydroxy-2-oxo-3-quinolinecarboxamide

C20H21N3O3 (351.1583)


   
   

N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-2-(2,3,5-trimethylphenoxy)acetamide

N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]-2-(2,3,5-trimethylphenoxy)acetamide

C20H21N3O3 (351.1583)


   

4-[(1-methyl-2-oxo-4-quinolinyl)oxy]-N-(4-methyl-2-pyridinyl)butanamide

4-[(1-methyl-2-oxo-4-quinolinyl)oxy]-N-(4-methyl-2-pyridinyl)butanamide

C20H21N3O3 (351.1583)


   

N-(3,4-dimethylphenyl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide

N-(3,4-dimethylphenyl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide

C20H21N3OS (351.1405)


   

N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide

N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide

C20H21N3OS (351.1405)


   

O-beta-D-Xylosylzeatin

O-beta-D-Xylosylzeatin

C15H21N5O5 (351.1543)


   

(E)-N-cyclohexyl-3-(4-nitrophenyl)-N-pyridin-2-ylprop-2-enamide

(E)-N-cyclohexyl-3-(4-nitrophenyl)-N-pyridin-2-ylprop-2-enamide

C20H21N3O3 (351.1583)


   

N-[2-(cyclohexen-1-yl)ethyl]-2-(4-oxochromeno[4,3-c]pyrazol-1-yl)acetamide

N-[2-(cyclohexen-1-yl)ethyl]-2-(4-oxochromeno[4,3-c]pyrazol-1-yl)acetamide

C20H21N3O3 (351.1583)


   

4-[3-(2-Phenoxyethoxy)-2-quinoxalinyl]morpholine

4-[3-(2-Phenoxyethoxy)-2-quinoxalinyl]morpholine

C20H21N3O3 (351.1583)


   

4-[5-(4-methoxyphenyl)-3-isoxazolyl]-N-(2-pyridinylmethyl)butanamide

4-[5-(4-methoxyphenyl)-3-isoxazolyl]-N-(2-pyridinylmethyl)butanamide

C20H21N3O3 (351.1583)


   

N-[(2-methoxyphenyl)methyl]-2-methyl-3-prop-2-enoxy-6-indazolecarboxamide

N-[(2-methoxyphenyl)methyl]-2-methyl-3-prop-2-enoxy-6-indazolecarboxamide

C20H21N3O3 (351.1583)


   

1-butyl-4-hydroxy-N-(3-methyl-2-pyridinyl)-2-oxo-3-quinolinecarboxamide

1-butyl-4-hydroxy-N-(3-methyl-2-pyridinyl)-2-oxo-3-quinolinecarboxamide

C20H21N3O3 (351.1583)


   

[(3Z)-2-oxo-3-(1,3,3-trimethylindol-2-ylidene)propyl] 4-hydroxybenzoate

[(3Z)-2-oxo-3-(1,3,3-trimethylindol-2-ylidene)propyl] 4-hydroxybenzoate

C21H21NO4 (351.1471)


   

Phe-Ala-Asp

Phe-Ala-Asp

C16H21N3O6 (351.143)


A tripeptide composed of L-phenylalanine, L-alanine, and L-aspartic acid joined by peptide linkages.

   
   
   
   
   

beta-D-tyvelosyl-(1->3)-N-acetyl-beta-D-galactosamine

beta-D-tyvelosyl-(1->3)-N-acetyl-beta-D-galactosamine

C14H25NO9 (351.1529)


   

Methyl 4-(5-{[(2-hydroxy-2-phenylethyl)amino]methyl}furan-2-yl)benzoate

Methyl 4-(5-{[(2-hydroxy-2-phenylethyl)amino]methyl}furan-2-yl)benzoate

C21H21NO4 (351.1471)


   

2-[(2S,3R,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2S,3R,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C17H22FN3O4 (351.1594)


   

2-[(2S,3S,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2S,3S,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C17H22FN3O4 (351.1594)


   

1-[(2S,3S)-2-(hydroxymethyl)-6-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

1-[(2S,3S)-2-(hydroxymethyl)-6-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C20H21N3O3 (351.1583)


   

1-[(2S,3R)-2-(hydroxymethyl)-6-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

1-[(2S,3R)-2-(hydroxymethyl)-6-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C20H21N3O3 (351.1583)


   

2-[(2S,3R,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2S,3R,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C17H22FN3O4 (351.1594)


   

2-[(2R,3S,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2R,3S,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C17H22FN3O4 (351.1594)


   

2-[(2R,3S,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2R,3S,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C17H22FN3O4 (351.1594)


   

2-[(2R,3R,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2R,3R,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C17H22FN3O4 (351.1594)


   

2-[(2S,3S,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2S,3S,6S)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C17H22FN3O4 (351.1594)


   

2-[(2R,3R,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2R,3R,6R)-3-[[(3-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C17H22FN3O4 (351.1594)


   

1-[(2R,3R)-2-(hydroxymethyl)-6-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

1-[(2R,3R)-2-(hydroxymethyl)-6-[oxo(2-pyridinyl)methyl]-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]ethanone

C20H21N3O3 (351.1583)


   

1-Hydroxy-5-methoxy-3-methyl-6-[[7-(3-methyl-1,3-butadienyl)-1H-indole-3-yl]methyl]pyrazine-2(1H)-one

1-Hydroxy-5-methoxy-3-methyl-6-[[7-(3-methyl-1,3-butadienyl)-1H-indole-3-yl]methyl]pyrazine-2(1H)-one

C20H21N3O3 (351.1583)


   
   
   
   
   
   
   
   

4,6-diphenyl-N-[(E)-pyridin-3-ylmethylideneamino]pyrimidin-2-amine

4,6-diphenyl-N-[(E)-pyridin-3-ylmethylideneamino]pyrimidin-2-amine

C22H17N5 (351.1484)


   

Methyl 2,2-dimethyl-5-(naphthalen-1-yliminomethyl)-4,6-dioxocyclohexane-1-carboxylate

Methyl 2,2-dimethyl-5-(naphthalen-1-yliminomethyl)-4,6-dioxocyclohexane-1-carboxylate

C21H21NO4 (351.1471)


   

1-Benzyl-3,4-bis(methoxycarbonyl)-2-phenyl-3-pyrroline

1-Benzyl-3,4-bis(methoxycarbonyl)-2-phenyl-3-pyrroline

C21H21NO4 (351.1471)


   

1-Methyl-2,5-diphenyl-2,5-dihydro-1H-pyrrole-3,4-dicarboxylic acid dimethyl ester

1-Methyl-2,5-diphenyl-2,5-dihydro-1H-pyrrole-3,4-dicarboxylic acid dimethyl ester

C21H21NO4 (351.1471)


   

beta-D-Tyvp-(1->3)-beta-D-GalpNAc

beta-D-Tyvp-(1->3)-beta-D-GalpNAc

C14H25NO9 (351.1529)


An amino disaccharide consisting of N-acetyl-beta-D-galactosamine having a beta-D-tyvelosyl residue attached at the 3-position.

   
   
   
   

IMT1

IMT1

C21H21NO4 (351.1471)


IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1 reduces deoxynucleoside triphosphate levels and citric acid cycle intermediates, resulting in a marked depletion of cellular amino acid levels. IMT1 has the potential for mitochondrial transcription disorders related diseases[1].

   

NAB-14

NAB-14

C20H21N3O3 (351.1583)


NAB-14 is a potent, selective, orally active and non-competitive GluN2C/2D antagonists with an IC50 of 580 nM for GluN1/GluN2D. NAB-14 shows >800-fold selective for recombinant GluN2C and GluN2D over GluN2A and GluN2B. NAB-14 can cross the blood-brain-barrier[1].

   

1-hydroxy-5-methoxy-3-methyl-6-{[7-(3-methylbuta-1,3-dien-1-yl)-1h-indol-3-yl]methyl}pyrazin-2-one

1-hydroxy-5-methoxy-3-methyl-6-{[7-(3-methylbuta-1,3-dien-1-yl)-1h-indol-3-yl]methyl}pyrazin-2-one

C20H21N3O3 (351.1583)


   

16-methoxy-6,11,11-trimethyl-5,8,13-triazatetracyclo[10.7.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(12),2,9,14,16,18-hexaene-4,7-dione

16-methoxy-6,11,11-trimethyl-5,8,13-triazatetracyclo[10.7.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(12),2,9,14,16,18-hexaene-4,7-dione

C20H21N3O3 (351.1583)


   

(2-{14-methoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11(19),12,14-heptaen-12-yl}ethyl)dimethylamine

(2-{14-methoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11(19),12,14-heptaen-12-yl}ethyl)dimethylamine

C21H21NO4 (351.1471)


   

14,15,16-trimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-5-ol

14,15,16-trimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-5-ol

C21H21NO4 (351.1471)


   

(2r,3r,4s,5s)-2-(6-{[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5s)-2-(6-{[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


   

3-methanesulfonyl-n-methyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enamide

3-methanesulfonyl-n-methyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enamide

C18H25NO4S (351.1504)


   

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]butan-1-one

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]butan-1-one

C21H21NO4 (351.1471)


   

2-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

2-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


   

3,4,11-trimethoxy-13-methyl-7,8-dihydro-6-azatetraphen-10-one

3,4,11-trimethoxy-13-methyl-7,8-dihydro-6-azatetraphen-10-one

C21H21NO4 (351.1471)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-3-phenylpropanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(1h-indol-3-yl)propylidene]amino}-3-phenylpropanoic acid

C20H21N3O3 (351.1583)


   

methyl 3-[(dimethylcarbamoyl)methyl]-2-(4-methylphenyl)imidazo[1,2-a]pyridine-6-carboxylate

methyl 3-[(dimethylcarbamoyl)methyl]-2-(4-methylphenyl)imidazo[1,2-a]pyridine-6-carboxylate

C20H21N3O3 (351.1583)


   

(2s,3r)-3-chloro-2-(3,4-dimethylpent-3-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboxylic acid

(2s,3r)-3-chloro-2-(3,4-dimethylpent-3-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboxylic acid

C19H26ClNO3 (351.1601)


   

(5ar)-2-ethanimidoyl-1-hydroxy-5,5-dimethyl-10-(methylamino)-5ah,6h-naphtho[2,3-a]pyrrolizine-3,11-dione

(5ar)-2-ethanimidoyl-1-hydroxy-5,5-dimethyl-10-(methylamino)-5ah,6h-naphtho[2,3-a]pyrrolizine-3,11-dione

C20H21N3O3 (351.1583)


   

7'-methoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-6'-ol

7'-methoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-6'-ol

C21H21NO4 (351.1471)


   

5,7-dihydroxy-6-(1-methylpiperidin-2-yl)-2-phenylchromen-4-one

5,7-dihydroxy-6-(1-methylpiperidin-2-yl)-2-phenylchromen-4-one

C21H21NO4 (351.1471)


   

7-(2h-1,3-benzodioxol-5-yl)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-8-ol

7-(2h-1,3-benzodioxol-5-yl)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-8-ol

C21H21NO4 (351.1471)


   

7-hydroxy-5-methoxy-2-phenyl-8-(piperidin-2-yl)chromen-4-one

7-hydroxy-5-methoxy-2-phenyl-8-(piperidin-2-yl)chromen-4-one

C21H21NO4 (351.1471)


   

2-ethanimidoyl-1-hydroxy-5,5-dimethyl-10-(methylamino)-5ah,6h-naphtho[2,3-a]pyrrolizine-3,11-dione

2-ethanimidoyl-1-hydroxy-5,5-dimethyl-10-(methylamino)-5ah,6h-naphtho[2,3-a]pyrrolizine-3,11-dione

C20H21N3O3 (351.1583)


   

4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaene

4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaene

C21H21NO4 (351.1471)


   

(2r,3r)-3-chloro-2-(3,4-dimethylpent-3-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboxylic acid

(2r,3r)-3-chloro-2-(3,4-dimethylpent-3-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboxylic acid

C19H26ClNO3 (351.1601)


   

15,16-dimethoxy-21-methyl-4,6-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0³,⁷.0¹³,¹⁸]henicosa-1(12),2(10),3(7),8,13(18),14,16-heptaene

15,16-dimethoxy-21-methyl-4,6-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0³,⁷.0¹³,¹⁸]henicosa-1(12),2(10),3(7),8,13(18),14,16-heptaene

C21H21NO4 (351.1471)


   

3-chloro-2-(3,4-dimethylpent-3-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboxylic acid

3-chloro-2-(3,4-dimethylpent-3-en-1-yl)-2-(methoxymethyl)-3,4-dihydro-1h-quinoline-6-carboxylic acid

C19H26ClNO3 (351.1601)


   

(2z,6r,9z)-4-hydroxy-16-methoxy-6,11,11-trimethyl-5,8,13-triazatetracyclo[10.7.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(12),2,4,9,14,16,18-heptaen-7-one

(2z,6r,9z)-4-hydroxy-16-methoxy-6,11,11-trimethyl-5,8,13-triazatetracyclo[10.7.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(12),2,4,9,14,16,18-heptaen-7-one

C20H21N3O3 (351.1583)


   

(8r,8as)-7-(2h-1,3-benzodioxol-5-yl)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-8-ol

(8r,8as)-7-(2h-1,3-benzodioxol-5-yl)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-8-ol

C21H21NO4 (351.1471)


   

(2s,3r,4s,5r)-2-(6-{[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2s,3r,4s,5r)-2-(6-{[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


   

(2e)-3-methanesulfonyl-n-methyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enamide

(2e)-3-methanesulfonyl-n-methyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enamide

C18H25NO4S (351.1504)


   

3,4,10,11-tetramethoxy-5h-6-azatetraphene

3,4,10,11-tetramethoxy-5h-6-azatetraphene

C21H21NO4 (351.1471)


   

1-(hydroxymethyl)-5-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,4-tetrol

1-(hydroxymethyl)-5-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,4-tetrol

C14H25NO9 (351.1529)